MedTrace Logo

The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia

NCT04598750 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250

Last updated 2024-10-09

No results posted yet for this study

Summary

This is a prospective observational study designed to evaluate Immature Platelet Fraction or Immature Platelet Count and Platelet Function Analyzer-100/200 Closure Time-ADP (in vitro bleeding time) as markers of bleeding risk in thrombocytopenic preterm neonates admitted to the Neonatal Intensive Care Unit.

Conditions

Sponsors & Collaborators

  • Karolinska University Hospital

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Boston Children's Hospital

    collaborator OTHER

  • Harvard Medical School (HMS and HSDM)

    collaborator OTHER

  • Region Stockholm

    collaborator OTHER_GOV

  • The Swedish Society of Medicine

    collaborator OTHER

  • Karolinska Institutet

    lead OTHER

Principal Investigators

  • Emöke Deschmann, MD, PhD · Karolinska Institutet

  • Robert Christensen, MD · University of Utah Medical Center

Eligibility

Min Age
1 Day
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-06-15
Primary Completion
2025-12-31
Completion
2025-12-31

Countries

  • United States
  • Netherlands
  • Sweden

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04598750 on ClinicalTrials.gov